[1] Abbas, A. M., Salem, H., & Orabi, A. S. (2024). Synthesis, characterization, in vitro and in silico assessment of novel diclofenac derivative metal complexes. Journal of Molecular Structure, Article 139191. https://doi.org/10.1016/j.molstruc.2024.139191
[2] Abd El-Mageed, M. M. (2023). The investigation for eradication and inhibition of Gram-positive and Gram-negative bacteria by metal zinc oxide nanoparticles. Al-Azhar Journal of Agricultural Research. https://doi.org/10.21608/ajar.2023.316056
[3] Abd El-Lateef, H. M., El-Dabea, T., Khalaf, M. M., & Abu-Dief, A. M. (2022). Development of metal complexes for treatment of coronaviruses. International Journal of Molecular Sciences, 23(11), Article 6418. https://doi.org/10.3390/ijms23126418
[4] Abdolmaleki, S., Aliabadi, A., & Khaksar, S. (2024a). Riding the metal wave: A review of the latest developments in metal-based anticancer agents. Coordination Chemistry Reviews, 501, Article 215579. https://doi.org/10.1016/j.ccr.2023.215579
[5] Abdolmaleki, S., Aliabadi, A., & Khaksar, S. (2024b). Unveiling the promising anticancer effect of copper-based compounds: A comprehensive review. Journal of Cancer Research and Clinical Oncology, 150(2), Article 81. https://doi.org/10.1007/s00432-024-05641-5
[6] Abdul-Hassan, M. M., & Mousa, N. K. (2020). Antimicrobial activity of new transition metal complexes of sulfamethoxazole on nhibiter by Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhi and Escherichia coli. International Conference of Numerical Analysis and Applied Mathematics ICNAAM 2019.
[7] Adeleke, A. A., Islam, M. S., & Omondi, B. O. (2022). Silver(I) pyridinyl complexes with benzothiazole, thiophene, and furan moieties: DNA/protein‐binding, antibacterial, antioxidant, and anticancer studies. Archiv Der Pharmazie, 355(11), Article e2200308. https://doi.org/10.1002/ardp.202200308
[8] Alav, I., Pordelkhaki, P., de Resende, P. E., Partington, H., Gibbons, S., Lord, R. M., & Buckner, M. M. C. (2023). Metal complexes and conjugation: Harnessing the power of cobalt complexes to curtail plasmid transfer. bioRxiv. https://doi.org/10.1101/2023.11.24.568573
[9] Ale Ebrahim, S., Ashtari, A., Zamani Pedram, M., & Ale Ebrahim, N. (2019). Publication trends in drug delivery and magnetic nanoparticles. Nanoscale Research Letters, 14(1), Article 164. https://doi.org/10.1186/s11671-019-2994-y
[10] Alvarez, L., Arnesano, F., Natile, G., & Fanizzi, F. P. (2023). The development of metal‐based antioxidants as anticancer agents. Encyclopedia of Inorganic and Bioinorganic Chemistry. https://doi.org/10.1002/9781119951438.eibc2856
[11] Anitha, N., Lakshmi, P. J., Ravi, M., Devi, C. S., & Sarala, C. (2023). Experimental and theoretical studies on structural aspects of transition metal complexes of isonicotinoyl N‐oxide hydrazone: Their DNA‐binding interaction and cytotoxicity. Applied Organometallic Chemistry, 37(12), Article e7289. https://doi.org/10.1002/aoc.7289
[12] Atalay, E., Çetinkaya, A., Koç, H. K., Karabıyık, H., Karabıyık, H., Üstün, E., Özdemir, İ., & Nasir, H. (2023). Synthesis, characterization and antimicrobial properties of silver complexes derived from 5,6-dimethylbenzimidazol-2-ylidene. Polyhedron, 241, Article 116383. https://doi.org/10.1016/j.poly.2023.116383
[13] Baile, M. B., Kolhe, N. S., Deotarse, P. P., Jain, A. S., & Jain, A. K. (2015). Metal ion complex -potential anticancer drug- A review. Rroij.com. https://www.rroij.com/open-access/metal-ion-complex-potential-anticancer-drug-a-review.pdf
[14] Belkhir-Talbi, D., Belkhir-Talbi, D., Makhloufi-Chebli, M., Terrachet-Bouaziz, S., Hikem-Oukacha, D., Ghemmit, N., Ismaili, L., Silva, A. M. S., & Hamdi, M. (2019). Synthesis, characterization, theoretical studies, ADMET and drug-likeness analysis: Electrochemical and biological activities of metal complexes of 3-(2-hydroxybenzoyl)-2H-chromen-2-one. Journal of Molecular Structure, 1181, 18–28. https://doi.org/10.1016/j.molstruc.2018.11.035
[15] Berking, B. B., Rijpkema, S. J., Zhang, B. H. E., Sait, A., Amatdjais-Groenen, H., Wilson, D. A., & Groenen, H. (2024). Biofilm disruption from within: Light-activated molecular drill-functionalized polymersomes bridge the gap between membrane damage and quorum sensing-mediated cell death. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.4c01177
[16] Bonaccorso, C., Marzo, T., & La Mendola, D. (2019). Biological applications of thiocarbohydrazones and their metal complexes: A perspective review. Pharmaceuticals, 13(1), Article 4. https://doi.org/10.3390/ph13010004
[17] Bordbar, M., Tabatabaee, M., Alizadeh-Nouqi, M., Mehri-Lighvan, Z., Khavasi, H. R., Yeganeh-Faal, A., Fallahian, F., & Dolati, M. (2016). Synthesis, characterization, cytotoxic activity and DNA-binding studies of cobalt (II) mixed-ligand complex containing pyridine-2,6-dicarboxylate ion and 2-aminopyrimidine. Journal of the Iranian Chemical Society, 13(10), 1891–1901. https://doi.org/10.1007/s13738-016-0826-x
[18] Boros, E., Dyson, P. J., & Gasser, G. (2020). Cell.com. https://www.cell.com/chem/pdf/S2451-9294(19)30467-X.pdf
[19] Bouraguba, M., Schmitt, A. M., Suseela, Y. V., Vileno, B., Melin, F., Glattard, E., Orvain, C., Lebrun, V., Raibaut, L., Ilbert, M., Bechinger, B., Hellwig, P., Gaiddon, C., Sour, A., & Faller, P. (2024). Quest for a stable Cu-ligand complex with a high catalytic activity to produce ROS. Metallomics, 16(3), Article mfae020. https://doi.org/10.1093/mtomcs/mfae020
[20] Bugalia, S., Dhayal, Y., Sachdeva, H., Kumari, S., Atal, K., Phageria, U., Saini, P., & Gurjar, O. P. (2023). Review on isatin- A remarkable scaffold for designing potential therapeutic complexes and its macrocyclic complexes with transition metals. Journal of Inorganic and Organometallic Polymers and Materials, 33(7), 1782–1801. https://doi.org/10.1007/s10904-023-02666-0
[21] Cai, D.-H., Liang, B.-F., Chen, B., Liu, Q.-Y., Pan, Z.-Y., Le, X., & He, L. (2023). A novel water-soluble Cu(II) gluconate complex inhibits cancer cell growth by triggering apoptosis and ferroptosis related mechanisms. Journal of Inorganic Biochemistry, 248, Article 112299. https://doi.org/10.1016/j.jinorgbio.2023.112299
[22] Carter, A., Racey, S. N., & Veuger, S. (2022). The role of iron in DNA and genomic instability in cancer, a target for iron chelators that can induce ROS. Applied Sciences, 12(19), Article 9161. https://doi.org/10.3390/app12199161
[23] Chen, E. H.-L., Wang, C.-H., Liao, Y.-T., Chan, F.-Y., Kanaoka, Y., Uchihashi, T., Kato, K., Lai, L., Chang, Y.-W., Ho, M.-C., & Chen, R. P.-Y. (2023). Visualizing the membrane disruption action of antimicrobial peptides by cryo-electron tomography. Nature Communications, 14(1), Article 5464. https://doi.org/10.1038/s41467-023-41156-2
[24] Claudel, M., Schwarte, J. V., & Fromm, K. M. (2020). New antimicrobial strategies based on metal complexes. Chemistry, 2(4), 849–899. https://doi.org/10.3390/chemistry2040056
[25] Dasna, W., Mariyam, D., Wijaya, H. W., Arrozi, U. F., & Sugiarto, S. (2023). Synthesis, structural determination and antibacterial properties of zinc(II) complexes containing 4-aminopyridine ligands. Indonesian Journal of Chemistry, 23(4), 1134–1143. https://doi.org/10.22146/ijc.82801
[26] Desoize, B. (2004). Metals and metal compounds in cancer treatment. Anticancer Research, 24(3a), 1529–1544. http://ar.iiarjournals.org/content/24/3A/1529.abstract
[27] El-Desouky, M. A., El-Bindary, A. A., El-Afify, M., & Abd-Alim, N. (2022). Synthesis, characterization, theoretical calculation, DNA binding, molecular docking, anticovid-19 and anticancer chelation studies of some transition metal complexes. Inorganic and Nano-Metal Chemistry, 52(12), 1501–1516. https://doi.org/10.1080/24701556.2022.2047072
[28] Emara, E. M., El-Sayed, W. A., Khalaf, A. S. A., Alminderej, F. M., Abdel-Monem, Y. K., & Abd-Rabou, A. A. (2022). Spectral studies, thermal investigations and anticancer activity of some divalent metal complexes derived from 2‐(4‐bromophenylamino)acetohydrazide ligand. Applied Organometallic Chemistry, 36(5), Article e6657. https://doi.org/10.1002/aoc.6657
[29] Frei, A., Zuegg, J., Elliott, A. G., Baker, M. V., Braese, S., Brown, C. L., Chen, F., Dowson, C. G., Dujardin, G., Jung, N., King, A. P., Mansour, A. M., Massi, M., Moat, J., Mohamed, H. A., Renfrew, A. K., Rutledge, P. J., Sadler, P. J., Todd, M. H., ... Blaskovich, M. A. T. (2020). Metal complexes as a promising source for new antibiotics. Chemical Science, 11(10), 2627–2639. https://doi.org/10.1039/c9sc06460e
[30] Chandra, S., & Kumar, U. (2004). EPR, mass, IR, electronic, and magnetic studies on copper(II) complexes of semicarbazones and thiosemicarbazones. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 60(12), 2825-2832. https://doi.org/10.1016/j.saa.2004.03.040
[31] Djoko, K. Y., Goytia, M. M., Donnelly, P. S., Schembri, M. A., Shafer, W. M., & McEwan, A. G. (2015). Copper(II)-bis(thiosemicarbazonato) complexes as antibacterial agents: Insights into their mode of action and potential as therapeutics. Antimicrobial Agents and Chemotherapy, 59(10), 6444–6453. https://doi.org/10.1128/AAC.01289-15
[32] Fabra, D., et al. (2024). Proving the antimicrobial therapeutic activity on a new copper-thiosemicarbazone complex. Molecular Pharmaceutics, 21(4), 1987-1997. https://doi.org/10.1021/acs.molpharmaceut.3c01235
[33] Graur, V., Shova, S., Tsapkov, V., & Gulea, A. (2024). Synthesis, X-ray and antibacterial activity of new copper(II) thiosemicarbazone complexes derived from 4-formyl-3-hydroxy-2-naphthoic acid. Inorganica Chimica Acta, 571, 122216. https://doi.org/10.1016/j.ica.2024.122216
[34] Pinheiro, A. C., Nunes, I. J., Ferreira, W. V., Tomasini, P. P., Trindade, C., Martins, C. C., Wilhelm, E. A., Oliboni, R. d. S., Netz, P. A., Stieler, R., Casagrande, O. d. L., Jr., & Saffi, J. (2023). Antioxidant and anticancer potential of the new Cu(II) complexes bearing imine-phenolate ligands with pendant amine N-donor groups. Pharmaceutics, 15(2), 376. https://doi.org/10.3390/pharmaceutics15020376
[35] Rafique, S., Idrees, M., Nasim, A., Akbar, H., & Atha, A. (2010). Transition metal complexes as potential therapeutic agents. Biotechnology and Molecular Biology Reviews, 2010(2), 38–45.
[36] Rodríguez, I., Flores Bello, J., Marie Serrano Valcárcel, J., & López-Mejías, V. (2020). Design of potential pharmaceutical-based metal complexes derived from cromolyn a mast cell stabilizer. ACS Omega, 5(46), 29714–29721. https://doi.org/10.1021/acsomega.0c03320
[37] Shao, Y. M., Sharavyn, B., Huang, P., Naranmandura, H., & Wang, Q. Q. (2022). Development of metal-based drugs and application in clinical treatment. The Natural Products Journal, 12(3). https://doi.org/10.2174/2210315511666210512025010
[38] Sharma, B., Shukla, S., Rattan, R., Fatima, M., Goel, M., Bhat, M., Dutta, S., Ranjan, R. K., & Sharma, M. (2022). Antimicrobial agents based on metal complexes: Present situation and future prospects. International Journal of Biomaterials, 2022, 1–21. https://doi.org/10.1155/2022/6819080
[39] Singh, D., Saxena, B. B., Singh, V. K., Akhtar, M. F. (2024). Application of organic complex compounds as drug. International Journal For Multidisciplinary Research. https://doi.org/10.36948/ijfmr.2024.v06i04.24900
[40] Springer, C., Humayun, D., & Skouta, R. (2024). Cuproptosis: Unraveling the mechanisms of copper-induced cell death and its implication in cancer therapy. Cancers, 16(3), 647. https://doi.org/10.3390/cancers16030647
[41] Study on Biological Activity. (2024). Study of biological activity of mixed ligand of some 3d metal complexes against clinically microbial isolates. https://doi.org/10.61921/kyauj.v06i01.001
[42] Tole, T., Jordaan, J., & Vosloo, H. (2018). Synthesis and application of the transition metal complexes of α-pyridinyl alcohols, α-bipyridinyl alcohols, α,α’-pyridinyl diols and α,α’-bipyridinyl diols in homogeneous catalysis. Molecules, 23(4), 896. https://doi.org/10.3390/molecules23040896
[43] Topkaya, C. (2024). Experimental biological studies of novel tetradentate hydrazone Cu(II) complexes for potential applications in medicinal chemistry. Macedonian Journal of Chemistry and Chemical Engineering. https://doi.org/10.20450/mjcce.2024.2751
[44] Tripathi, V. D., & Mohammed, H. S. (2020). Medicinal applications of coordination complexes. Journal of Physics: Conference Series, 1664(1), 012070. https://doi.org/10.1088/1742-6596/1664/1/012070
[45] Turnbull, T. (2022). Essential metals in health and disease. Chemico-Biological Interactions, 367, 110173. https://doi.org/10.1016/j.cbi.2022.110173
[46] Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., ... Golub, T. R. (2022). Copper induces cell death by targeting lipoylated TCA cycle proteins. Science, 375(6586), 1254–1261. https://doi.org/10.1126/science.abf0529
[47] Wang, P., & Yuan, Y. (2021). Biological applications of copper-containing materials. Bioactive Materials, 6(4), 916-927. https://doi.org/10.1016/j.bioactmat.2020.09.017
[48] Wang, X., Zhang, Y., & Li, J. (2024). Copper-based nanomaterials for biomedical applications. Chemical Engineering Journal, 149040. https://doi.org/10.1016/j.cej.2024.149040
[49] Warnke, P. H., & Warnke, C. (2025). Antiviral effects of copper and copper alloy and the underlying mechanisms in severe acute respiratory syndrome coronavirus 2. Hazards Advances, 100589. https://doi.org/10.1016/j.hazadv.2025.100589
[50] White, C., Lee, J., Kambe, T., Fritsche, K., & Petris, M. J. (2012). Copper homeostasis at the host-pathogen interface. Journal of Biological Chemistry, 287(17), 13549-13555. https://doi.org/10.1074/jbc.R111.316406
[51] Xie, J., Yang, Y., Gao, Y., He, J., & et al. (2023). Cuproptosis: mechanisms and links with cancers. Molecular Cancer, 22(46). https://doi.org/10.1186/s12943-023-01732-y
[52] Zainab, S., Ashraf, A., Siddiqui, W. A., Raza, M. A., Niaz, S., Zaib, J., Arshad, M., Aman, F., & Sandhu, Z. A. (2024). Piroxicam analogue metal complexes: Synthesis, crystal structures, molecular modeling and biological studies. Applied Organometallic Chemistry. https://doi.org/10.1002/aoc.7481
[53] Zavaroni, A., Rigamonti, L., Bisceglie, F., Carcelli, M., Pelosi, G., Gentilomi, G. A., Rogolino, D., & Bonvicini, F. (2025). Antimicrobial activity of copper(II), nickel(II) and zinc(II) complexes with semicarbazone and thiosemicarbazone ligands derived from substituted salicylaldehydes. Molecules, 30(11), 2329. https://doi.org/10.3390/molecules30112329
[54] Zhang, C. X., & Lippard, S. J. (2003). New metal complexes as potential therapeutics. Current Opinion in Chemical Biology, 7(4), 481–489. https://doi.org/10.1016/s1367-5931(03)00081-4
[55] Zhang, W., Song, Z., Tian, Y., Zhang, R., Guo, Z., Yang, Y., Jiang, X., & Zhang, R. (2024). Copper homeostasis and cuproptosis: Exploring novel therapeutic strategies for connective tissue diseases. International Immunopharmacology, 136, 113698. https://doi.org/10.1016/j.intimp.2024.113698
[56] Iftikhar, B., Javed, K., Khan, M. S. U., Akhter, Z., Mirza, B., & Mckee, V. (2018). Synthesis, characterization and biological assay of Salicylaldehyde Schiff base Cu (II) complexes and their precursors. Journal of Molecular Structure, 1155, 337-348.
[57] Middya, P., Basak, A., & Chattopadhyay, S. (2025). Recent advances in the synthesis, structure, property and application of copper (II) complexes of salicylaldehyde thiosemicarbazone derivatives. Inorganica Chimica Acta, 122861.
[58] Sarker, D., Karim, M. R., Haque, M. M., Zamir, R., & Asraf, M. A. (2019). Copper (II) complex of salicylaldehyde semicarbazone: Synthesis, characterization and antibacterial activity. Asian Journal of Chemical Sciences, 6(4), 1-8.
[59] Lee, P. F., Yang, C. T., Fan, D., Vittal, J. J., & Ranford, J. D. (2003). Synthesis, characterization and physicochemical properties of copper (II) complexes containing salicylaldehyde semicarbazone. Polyhedron, 22(20), 2781-2786.
[60] Pahonțu, E., Ilieș, D. C., Shova, S., Paraschivescu, C., Badea, M., Gulea, A., & Roșu, T. (2015). Synthesis, characterization, crystal structure and antimicrobial activity of copper (II) complexes with the Schiff base derived from 2-hydroxy-4-methoxybenzaldehyde. Molecules, 20(4), 5771-5792.
[61] Abdalla, O., Farina, Y., & Ibrahim, N. (2015). Synthesis, characterization and antibacterial study of copper (II) complexes of thiosemicarbazones. Malaysian Journal of Analytical Sciences, 19(6), 1171-1178.
[62] Chandra, S., & Gupta, L. K. (2005). EPR, mass, IR, electronic, and magnetic studies on copper (II) complexes of semicarbazones and thiosemicarbazones. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 61(1-2), 269-275.
[63] Venkatesh, G., Vennila, P., Kaya, S., Ahmed, S. B., Sumathi, P., Siva, V., ... & Kamal, C. (2024). Synthesis and spectroscopic characterization of Schiff base metal complexes, biological activity, and molecular docking studies. ACS omega, 9(7), 8123-8138.
[64] MFH, M. (2020). Structural investigation and antibacterial activity of Cu (II), Co (II), Ni (II) and Zn (II) complexes of a Schiff base derived from salicylaldehyde and thiosemicarbazide.
[65] Al-Riyahee, A. A., Horton, P. N., Coles, S. J., Amoroso, A. J., & Pope, S. J. (2022). Ni (II), Cu (II) and Zn (II) complexes of functionalised thiosemicarbazone ligands: Syntheses and reactivity, characterization and structural studies. Polyhedron, 225, 116079.
[66] Castiñeiras, A., Fernández-Hermida, N., García-Santos, I., Gómez-Rodríguez, L., Frontera, A., & Niclós-Gutiérrez, J. (2024). Synthesis, Structural Characterisation, and Electrochemical Properties of Copper (II) Complexes with Functionalized Thiosemicarbazones Derived from 5-Acetylbarbituric Acid. Molecules, 29(10), 2245.
[67] Khan, T., Zehra, S., Fatima, U. et al. Computational Drug Designing, Synthesis, Characterization and Anti-bacterial Activity Evaluation of Some Mixed Ligand–Metal Complexes of 2-hydroxybenzaldehydethiosemicarbazone as Primary Ligand. Chemistry Africa 6, 1943–1960 (2023). https://doi.org/10.1007/s42250-023-00640-4
[68] Joseph, J., Mary, N. L., & Sidambaram, R. (2010). Synthesis, characterization, and antibacterial activity of the Schiff bases derived from thiosemicarbazide, Salicylaldehyde, 5-bromosalicylaldehyde and their copper (II) and nickel (II) complexes. Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry, 40(10), 930-933.
[69] Ngece, K., Khwaza, V., Paca, A. M., & Aderibigbe, B. A. (2025). The Antimicrobial Efficacy of Copper Complexes: A Review. Antibiotics, 14(5), 516.
[70] Ceramella, J., Iacopetta, D., Catalano, A., Cirillo, F., Lappano, R., & Sinicropi, M. S. (2022). A review on the antimicrobial activity of Schiff bases: Data collection and recent studies. Antibiotics, 11(2), 191.
[71] Arthi, P., Dharmasivam, M., Kaya, B., & Rahiman, A. K. (2023). Multi-target activity of copper complexes: Antibacterial, DNA binding, and molecular docking with SARS-CoV-2 receptor. Chemico-Biological Interactions, 373, 110349.
[72] Yusuf, T. L., Waziri, I., Oladipo, S. D., Abd El-Maksoud, M. S., Muller, A. J., & Vatsha, B. (2025). Copper (II) Complexes Derived from Halogen-Substituted Schiff Base Ligands: Synthesis, Crystal Structures, Antibacterial Activity, and Molecular Docking Studies. ACS omega.
